Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001962926-26-000007

CHIEF SCIENTIFIC OFFICER acquired 11,817 shares (option exercise)

  • CHIEF SCIENTIFIC OFFICER acquired 11,817 shares (conversion)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-04 Option exercise 10b5-1 +11,817 $0.34 $4,018 240,777 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-04 Conversion 10b5-1 −11,817 228,960 D
Derivatives
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-04 Option exercise · Share Option (right to buy) 10b5-1 −11,817 154,715 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-04 Conversion · American Depositary Shares 10b5-1 +3,939 3,939 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-04 Sale · American Depositary Shares 10b5-1 −3,100 $49.29 $152,786 839 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-04 Sale · American Depositary Shares 10b5-1 −839 $50.03 $41,974 0 D
Loading xslF345X06/form4-08052026_080829.xml…